Zhibo Liu

机构：King University, Tongji University, University of Science and Technology of China, Northeast Normal University, Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, National Medical Products Administration, China-Japan Friendship Hospital, King Center, Peking University Cancer Hospital, Beijing National Laboratory for Molecular Sciences, Chengdu University, Institute of Metal Research, Chang Industry (United States), Ministry of Education, Beijing Tsinghua Chang Gung Hospital, First Affiliated Hospital of Zhengzhou University, Center for Life Sciences, China National Petroleum Corporation (China), Tsinghua University · ORCID：0000-0002-5587-4165

发表论文 308 篇 · 总被引 13801 次 · h-index 52

代表论文

• Boron neutron capture therapy preserves immune cells and induces robust anti-tumour immunity in preclinical mouse model (2026 · Nature Communications · 被引 9)
• Monoclonal antibody preparation and linear epitope identification for the ASFV A151R protein (2025 · BMC Veterinary Research · 被引 1)
• A Bioorthogonal DesilylationSystem Potentiates mRNATherapeutics in Tumors (2026 · Journal of the American Chemical Society)
• Nickel catalysis enables chemoselectivity in radiation chemistry (2026 · Nature Communications)
• Targeted therapy against recurrent anti-synthetase syndrome associated interstitial lung disease after bilateral lung transplantation guided by transcriptomic analyses: a case-based study (2026 · Frontiers in Immunology)
• A Radiocatalytic Conversion Platform Enables Upcycling of CHF 3 Waste to Fluorochemical (2026 · Chinese Journal of Chemistry)